GDF-15 blockade: A multi-directional approach to potentiate cancer immunotherapy and alleviate cancer cachexia

Keywords

cancer immunotherapy / cachexia / GDF-15 / visugromab

References

[1] Melero I, de Miguel Luken M, de Velasco G, et al. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours. Nature. 2025; 637: 1218-1227.

[2] Welsh JB, Sapinoso LM, Kern SG, et al, Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum PNAS. 2003; 100(6): 3410-3415

[3] Haake M, Haack B, Schäfer T, et al. Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. Nat Commun. 2023; 14(1): 4253.

[4] Wischhusen J, Melero I, Fridman WH. Growth/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint front Immunol. Front Immunol. 2020: 11: 951.

[5] Evans WJ, Morley JE, Argilés J, et al. Cachexia: a new definition. Clin Nutr. 2008; 27: 793-799.

[6] Lerner L, Tao J, Liu Q, et al. MAP3K11/GDF15 axis is a critical driver of cancer cachexia. J Cachexia Sarcopenia Muscle. 2015; 7(4): 467-482.

[7] Sabatini P, Frikke-Schmidt H, Arthurs J, et al. GFRAL-expressing neurons suppress food intake via aversive pathways. Proc Natl Acad Sci U S A. 2021; 118(8): e2021357118.

[8] Lim S, Brown J, Washington T, Greene NP, Development and progression of cancer cachexia: perspectives from bench to bedside. Sports Med Health Sci. 2020; 2(4): 177-185

[9] Mariean CR, Tiucă OM, Mariean A, Cotoi OS.Cancer cachexia: new insights and future directions. Cancers. 2023; 15: 5590

[10] Li J, Hu X, Xie Z, Li J, Huang C, Huang Y, Overview of growth differentiation factor 15 (GDF15) in metabolic diseases. Biomed Pharmacother. 2024; 176: 116809

[11] Albuquerque B, Chen X, Hirenallur-Shanthappa D, et al. Neutralization of GDF15 prevents anorexia and weight loss in the monocrotaline-induced cardiac cachexia rat model. Cells. 2022; 11(7): 1073.

[12] Huang Y, Wang J, Wei X, et al. GB18-06, a nanobody targeting GDF15, effectively alleviates weight loss and restores physical function in cachexia models. 2024. MAbs. 16(1).

[13] Groarke JD, Crawford J, Collins SM, et al. Ponsegromab for the treatment of cancer cachexia. N Engl J Med. 2024; 391: 2291-2303

[14] Winter L-M, Reinhardt D, Schatter A, et al. Molecular basis of GDF15 induction and suppression by drugs in cardiomyocytes and cancer cells toward precision medicine. Scientific Rep. 2023; 13: 12061

[15] Breen DM, Kim H, Bennett D, et al. GDF-15 Neutralization alleviates platinum-based chemotherapy-induced emesis, anorexia, and weight loss in mice and nonhuman primates. Cell Metab. 2020; 32(6): 938-950.e6

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.